354 related articles for article (PubMed ID: 26357625)
1. Hepatocellular Carcinoma and Liver Transplantation: State of the Art.
Mancuso A; Perricone G
J Clin Transl Hepatol; 2014 Sep; 2(3):176-81. PubMed ID: 26357625
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic liver transplantation for high-risk recurrent hepatocellular carcinoma.
Yang PC; Ho CM; Hu RH; Ho MC; Wu YM; Lee PH
World J Hepatol; 2016 Nov; 8(31):1309-1317. PubMed ID: 27872682
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation as a management of hepatocellular carcinoma.
Azzam AZ
World J Hepatol; 2015 Jun; 7(10):1347-54. PubMed ID: 26052380
[TBL] [Abstract][Full Text] [Related]
4. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
5. Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.
Herrero JI; Sangro B; Pardo F; Quiroga J; Iñarrairaegui M; Rotellar F; Montiel C; Alegre F; Prieto J
Liver Transpl; 2008 Mar; 14(3):272-8. PubMed ID: 18306328
[TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation for hepatocellular cancer: an (almost) exclusive Eastern procedure?
Pinheiro RS; Waisberg DR; Nacif LS; Rocha-Santos V; Arantes RM; Ducatti L; Martino RB; Lai Q; Andraus W; D'Albuquerque LAC
Transl Gastroenterol Hepatol; 2017; 2():68. PubMed ID: 28905009
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of transplantation for recurrence of hepatocellular carcinoma after liver resection.
Tuci F; Vitale A; D'Amico F; Gringeri E; Neri D; Zanus G; Bassi D; Polacco M; Boetto R; Lodo E; Germani G; Burra P; Angeli P; Cillo U
Transplant Proc; 2014 Sep; 46(7):2287-9. PubMed ID: 25242770
[TBL] [Abstract][Full Text] [Related]
8. [Liver transplantation for hepatocellular carcinoma].
Suh KS; Yi NJ
Korean J Hepatol; 2006 Dec; 12(4):493-506. PubMed ID: 17237627
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.
Menahem B; Lubrano J; Duvoux C; Mulliri A; Alves A; Costentin C; Mallat A; Launoy G; Laurent A
Liver Transpl; 2017 Jun; 23(6):836-844. PubMed ID: 28295992
[TBL] [Abstract][Full Text] [Related]
10. Sorafenib delays recurrence and metastasis after liver transplantation in a rat model of hepatocellular carcinoma with high expression of phosphorylated extracellular signal-regulated kinase.
Yan J; Tan C; Gu F; Jiang J; Xu M; Huang X; Dai Z; Wang Z; Fan J; Zhou J
Liver Transpl; 2013 May; 19(5):507-20. PubMed ID: 23408515
[TBL] [Abstract][Full Text] [Related]
11. Liver transplantation for hepatocellular carcinoma within the Milan criteria versus the University of California San Francisco criteria: a comparative study.
Abdelfattah MR; Elsiesy H; Al-Manea H; Broering DC
Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):398-403. PubMed ID: 29280920
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation.
Guerrini GP; Pinelli D; Di Benedetto F; Marini E; Corno V; Guizzetti M; Aluffi A; Zambelli M; Fagiuoli S; Lucà MG; Lucianetti A; Colledan M
Surg Oncol; 2016 Dec; 25(4):419-428. PubMed ID: 26403621
[TBL] [Abstract][Full Text] [Related]
13. Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.
Gunay Y; Guler N; Yaprak O; Dayangac M; Akyildiz M; Altaca G; Yuzer Y; Tokat Y
Indian J Surg; 2015 Dec; 77(Suppl 3):950-6. PubMed ID: 27011489
[TBL] [Abstract][Full Text] [Related]
14. Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence.
Rahimi RS; Trotter JF
Ann Gastroenterol; 2015; 28(3):323-330. PubMed ID: 26130250
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma beyond Milan criteria: Management and transplant selection criteria.
Elshamy M; Aucejo F; Menon KV; Eghtesad B
World J Hepatol; 2016 Jul; 8(21):874-80. PubMed ID: 27478537
[TBL] [Abstract][Full Text] [Related]
16. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
17. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.
Fuks D; Dokmak S; Paradis V; Diouf M; Durand F; Belghiti J
Hepatology; 2012 Jan; 55(1):132-40. PubMed ID: 21932387
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
19. Liver Transplantation for Advanced Hepatocellular Carcinoma after Downstaging Without Up-Front Stage Restrictions.
Chapman WC; Garcia-Aroz S; Vachharajani N; Fowler K; Saad N; Lin Y; Wellen J; Tan B; Khan AS; Doyle MB
J Am Coll Surg; 2017 Apr; 224(4):610-621. PubMed ID: 28069527
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for extrahepatic recurrence of hepatocellular carcinoma following liver transplantation.
Andreou A; Bahra M; Schmelzle M; Öllinger R; Sucher R; Sauer IM; Guel-Klein S; Struecker B; Eurich D; Klein F; Pascher A; Pratschke J; Seehofer D
Clin Transplant; 2016 Jul; 30(7):819-27. PubMed ID: 27107252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]